Center for Liver Diseases, The University of Chicago Medicine, Chicago, IL.
Department of Medicine, Loyola University Medical Center at Trinity Mercy Chicago, Chicago, IL.
Liver Transpl. 2021 Jul;27(7):1019-1031. doi: 10.1002/lt.26029. Epub 2021 Jun 24.
Recent modifications in organ allocation policies and increases in chronic liver diseases may have resulted in important changes in living donor liver transplantation (LDLT) in the United States. We examined the trends, outcomes, and factors associated with outcomes in adult LDLT. United Network for Organ Sharing data on 2566 adult LDLT recipients who received transplants from January 1, 2010, through December 31, 2019, were analyzed. LDLT graft and patient survival rates were compared with propensity score-matched deceased donor liver transplantation recipients by the Kaplan-Meier curve estimator. The association between preceding LDLT frequency and subsequent outcomes were assessed by Cox proportional hazards mixed effects modeling. After a stable annual frequency of LDLTs from 2010 to 2014 (~200 per year), the number of LDLTs doubled to 440 in 2019. The 1-year and 5-year graft survival rates for LDLT recipients were 88.4% and 78.1%, respectively, compared with 92.5% and 80.7% in the propensity score-matched donation after brain death recipients (P = 0.005), respectively. Older donor age and recipient diabetes mellitus and life support requirement were significantly associated with graft failure among LDLT recipients (P values <0.05). Average preceding LDLT frequencies of <3 per year, 3 to 20 per year, and >20 per year resulted in 1-year graft survival rates of 82%, 88% to 89%, and 93%, respectively (P values <0.05). There were 3 living donor deaths (0.12%). The frequency of LDLTs has doubled during the past decade, with good outcomes and acceptable donor safety profiles. However, there appear to be varying threshold transplant frequencies (volume/unit time) associated with acceptable (88%-89%) and aspirational (93%) 1-year graft survival rates. These data should be reassuring and encourage LDLT practice as efforts continue to expand the donor pool.
器官分配政策的最新修改和慢性肝病的增加可能导致美国活体供肝移植(LDLT)发生重大变化。我们研究了成人 LDLT 的趋势、结果和与结果相关的因素。分析了 2010 年 1 月 1 日至 2019 年 12 月 31 日期间,2566 名接受 LDLT 的成人 LDLT 受者的美国器官共享网络数据。通过 Kaplan-Meier 曲线估计器比较 LDLT 移植物和患者的存活率与倾向评分匹配的脑死亡后供肝移植受者。通过 Cox 比例风险混合效应模型评估先前 LDLT 频率与随后结果之间的关联。在 2010 年至 2014 年期间 LDLT 的年频率稳定(每年约 200 例)之后,2019 年 LDLT 的数量增加了一倍,达到 440 例。LDLT 受者的 1 年和 5 年移植物存活率分别为 88.4%和 78.1%,而倾向评分匹配的脑死亡后供者为 92.5%和 80.7%(P = 0.005)。供者年龄较大、受者糖尿病和生命支持需要与 LDLT 受者的移植物衰竭显著相关(P 值<0.05)。平均每年 LDLT 频率<3 次、3 至 20 次和>20 次,1 年移植物存活率分别为 82%、88%至 89%和 93%(P 值<0.05)。有 3 例活体供者死亡(0.12%)。在过去十年中,LDLT 的频率增加了一倍,结果良好,供者安全性可接受。然而,似乎存在不同的阈值移植频率(单位时间内的数量)与可接受的(88%-89%)和理想的(93%)1 年移植物存活率相关。这些数据应该令人安心,并鼓励 LDLT 实践,因为继续努力扩大供体库。